期刊文献+

趋化因子MCP-1、MIP-1α在EAE小鼠脊髓中的表达 被引量:8

The expressions of MCP-1 and MIP-1αin spinal cord of EAE mice
下载PDF
导出
摘要 目的:研究单核细胞趋化蛋白(MCP)-1和巨噬细胞炎性蛋白(MIP)-1α与实验性自身免疫性脑脊髓炎(EAE)发病的关系。方法:用髓鞘少突胶质细胞糖蛋白_(35-55)多肽加福氏完全佐剂皮下注射免疫C57BL/6小鼠建立EAE模型,用免疫组织化学方法观察EAE小鼠发病后第0天(初期)、第7天(高峰期)及第30天(恢复期)脊髓中MCP-1、MIP-1α的表达的变化,并通过免疫组化染色标记星形胶质细胞及小胶质细胞,判断MCP-1、MIP-1α的细胞来源。结果: MCP-1、MIP-1α在EAE小鼠发病初期脊髓中有少量表达,发病高峰期表达增高,而恢复期无表达,MCP-1主要由星形胶质细胞产生,MIP-1α主要由小胶质细胞产生;对照组小鼠脊髓中则没有MCP-1、MIP-1α表达。结论:趋化因子MCP-1、MIP-1α在EAE小鼠CNS不同胶质细胞中表达,是EAE发病早期募集免疫反应细胞向CNS浸润的重要致炎性因子。 Objective: To investigate the role of monocyte chemoattractant protein- 1 (MCP- 1) and macrophage inflammatory protein- 1α (MIP- 1α) in the pathogenesis of experimental autoimmune encephalomyelitis (EAE). Methods: EAE models in C57BL/6 mice were induced by injecting subcutaneously myelin oligodendrocyte glycoprotein (35-55) peptide in complete Freund's adjuvant. The expressions of MCP-1 and MIP-1α in the spinal cord at different stages of EAE were observed and the cellular source of MCP-1 or MIP-1α in CNS were identified respectively by staining using cell phenotype markers. Results: Reactive hypertrophic astrocytes were strongly immunoreactive for MCP-1, while MIP-1α was produced mainly by microglia. The productions in the CNS of these two chemokines were increased to correlate with disease development. Conclusion: Chemokines MCP-1 and MIP-1α are expressed in different glial cells in the CNS of EAE mice and are important proinflammatory cytokines for trafficing immune cells to infiltrate into CNS at initial stage of EAE.
出处 《脑与神经疾病杂志》 2007年第3期216-218,209,共4页 Journal of Brain and Nervous Diseases
关键词 实验性自身免疫性脑脊髓炎 多发性硬化 趋化因子 单核细胞趋化蛋白 巨噬细胞炎性蛋白 Experimental autoimmune encephalomyelitis Multiple sclerosis Chemokine Monocyte chemoattracant protein Macrophage inflammatory protein
  • 相关文献

参考文献8

  • 1徐全刚,王晓辉,黄德晖,吴卫平.MOG_(35-55)诱发实验性自身免疫性脑脊髓炎小鼠模型[J].中华神经医学杂志,2006,5(2):141-144. 被引量:19
  • 2Banisor I,Leist TP,Kalman B.Involvement of beta-chemokines in the development of inflammatory demyelination[J].J Neuroinflammation,2005;2(1):7~22
  • 3Alt C,Laschinger M,Engelhardt B.Functional expression of the lymphoid chemokines CCL19(ELC)and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in C-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis[J].Eur J Immunol,2002;32(8):2133~2144
  • 4Mahad DJ,Ransohoff RM.The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE)[J].Semin Immunol,2003;15(1):23~32
  • 5Van Der Voom P,Tekstra J,et al.Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions[J].Am J Pathol,1999;154(1):45~51218
  • 6Juedes AE,Hjelmstrom P,Bergman CM,et al.Kineties and cellular origin of cytokines in the central nervous system:insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis[J].J Immunol,2000;164 (1):419~426
  • 7Sunnemark D,Eltayeb S,Wallstrom E,et al.Differential expression of the chemokine receptors CXSCR1 and CCR1 by microglia and macrophages in myelin-oligodendrocyte-glycoprotein-induced experimental autoimmune encephalomyelitis[J].Brain Pathol,2003;13 (4):617~629
  • 8Trebst C,Sorensen TL,Kivisakk P,et al.CCRI+/CCR5+mononuclear phagocytes accumulate in the central nervous system of patients with multiplc sclerosis[J].Am J Pathol,2001;159(5):1701 ~1710

二级参考文献13

  • 1林嘉友.实验性变态反应性脑脊髓炎小鼠模型[J].中国免疫学杂志,1994,10(1):39-40. 被引量:11
  • 2Rao P, Segal BM. Experimental autoimmune encephalomyelitis [J].Methods Mol Med, 2004, 102: 363-375.
  • 3Bernard CC, Johns TG, Slavin A, et al. Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis[J]. J Mol Med, 1997, 75(2): 77-88.
  • 4Hjelmstrom P, Juedes AE, Ruddle NH, et al. Cytokines and antibodies in myelin oligodendrocyte glycoprotein-induced experimental allergic encephalomyelitis[J]. Res Immunol, 1998, 149(9): 794-804.
  • 5Sakuma H, Kohyama K, Park IK, et al. Clinicopathological study of a myelin oligodendrocyte glycoprotein-induced demyelinating disease in LEW.IAVI rats[J]. Brain, 2004, 127(Pt 10): 2201-2213.
  • 6Reindl M, Linington C, Brehm U, et al. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study[J]. Brain, 1999, 122(Pt 11): 2047-2056.
  • 7Berger T, Rubner P, Schautzer F, et al. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis atter a first demyelinating event[J]. N Engl J Med, 2003, 349(2): 139-145.
  • 8Costa O, Divoux D, Ischenko A, et al. Optimization of an animal model of experimental autoimmune encephalomyelitis achieved with a multiple MOG35-55 peptide in C57BL6/J strain of mice [J]. J Autoimmun, 2003, 20( 1): 51-61.
  • 9Tsunoda I, Kuang LQ, Theil DJ, et al. Antibody association with a novel model for primary progressive multiple sclerosis: induction of relapsing-remitting and progressive forms of EAE in H2s mouse strains[J]. Brain Pathol, 2000, 10(3): 402-418.
  • 10Zhang GX, Yu S, Gran B, et al. T cell and antibody responses in remitting-relapsing experimental autoimmune encephalomyelitis in(C57BL/6xSJL) F1 mice[J]. J Neuroimmunol, 2004, 148(1-2): 1-10.

共引文献18

同被引文献87

引证文献8

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部